Subscribe to our newsletter!
Follow the latest news from CATALIS and Clinical Trials Quebec
Governance
Efficient governance that brings tomorrow’s
progress today.
CATALIS’s governance relies on a network of public and private partners to carry out its vision and mission of progress and operational excellence in clinical research in Quebec. Advisory committees play a key role by supporting senior management in implementing the strategic plan and priority actions approved by the Board of Directors.
Board of directors
Me Jean Groleau, Me
Chairman of the Board of Directors
Lawyer and co-founder, Groleau Gauthier Plante LLP
Marc Rivière, MD
Former Chairman of the Board of Directors
General Partner & CMO, TVM Capital Life Science Inc.
Monique Lacroix, B. Pharm., M.Sc
Vice-Chair of the Board of Directors and Chair of the Human Resources and Governance Committee
Pharmacist, Clinical Research Professional and Guest Lecturer
Alain Couture
Member of the Board of Directors
Senior Manager, Government Affairs and Strategic Partnerships for Quebec, GSK
Diane Gosselin, PhD., MBA, ASC
Member of the Board of Directors
Corporate Director
Wilson Miller, MD
Member of the Board of Directors
Co-Director of Clinical Research, Lady Davis Institute, Jewish General Hospital Director
Patrick Montpetit, CPA
Member of the Board of Directors
Executive Chairman, Biodextris
Guy A. Rouleau, OQ, MD, PhD., FRCPC, FRSC
Member of the Board of Directors
Director of the Neuro, Director of Neurology and Neurosurgery, McGill University
Natalie Verreault, B.B.A., CAHR
Member of the Board of Directors
Senior Manager, Healthcare System and Government Affairs, Roche Canada
Observer members
Annie Blouin
Director, Organizational Support Directorate
Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec
Nathalie Girard
Strategic Projects Coordinator
Direction des sciences de la vie, Ministère de l’Économie, de l’Innovation et de l’Énergie du Québec
Valérie Perron, MAP, MBA
Executive Director
Direction principale de la performance, Sous-ministériat à la performance, Ministère de la Santé et des Services sociaux
Guests
Danika Laberge, PMP
President and CEO
CATALIS Québec
François Painchaud
Corporate Secretary
Lawyer and partner, Robic
Team
Presidency and executive management
Danika Laberge, PMP
President and CEO of CATALIS Quebec
Management team
Me Alexandra Obadia, LL.B., LL.M.
Chief Legal and Data Officer
Dorothy McKelvey
Director of Operations, Central Office
Stéphanie Lamarche, M.Sc., PMP
Program Director
Central office services
Mireille Dessureault, M.Sc.
FAST TRACK Evaluation Service Manager
Cristina Al-Ali
Project Lead
Kristina Amja, M.Sc.
Project Lead
Laurence Brière, B.Sc.
Project Lead
Dali Haddad
Project Lead
Lyes Bilal Khelladi
Project Lead
Marie-Ève Régo, B.Sc.
Project Lead
Sutton Smith, PhD.
Project Lead
Opérations
Xavier Bonhomme
Quality Systems and Training Specialist
Maya Bourjaily, CCRP, ACRP, BSI
Program Lead
Maryse Patenaude
Project Lead
Legal & ethics
Me Emily Kirby, LL.B., B.Sc., M.Env.
Lawyer and Ethics Specialist
Communications
Thomas de Brouwer, M.A.
Communications Manager
Orosca Houmey, M.A.
Communications Advisor
Finance
Line Darbelli
Administration and Accounting Manager
Tribute
CATALIS Québec wishes to pay tribute to Olga Vila, who served as Director of Finance and Administration from 2024 to 2026. Olga left a meaningful mark on our organization through her dedication, her rigor, and her commitment to integrity and good governance. She inspired her colleagues with her professionalism and kindness. The entire CATALIS Québec team wishes to express its deep sadness and extend its sincerest condolences to Olga’s family and loved ones.
In Memory of Olga Vila, CPA
Director of Finance and Administration (2024-2026)
History
In 2015-2016, Montreal InVivo identified a strategic need for Quebec, namely attracting more early clinical trials funded by the industry to get an edge in the world’s clinical research landscape. In 2017, following their lead, the Government of Quebec granted funding through the Québec Life Sciences Strategy, and the Ministère de l’Économie, de l’Innovation et de l’Énergie (Ministry of Health and Social Services) mandated the CQDM (biopharmaceutical research consortium) to launch this large-scale provincial initiative. CQDM founded the coordination office that led to the creation of CATALIS, which became a legal and independent body in 2018.
Today, CATALIS’s mission extends to all clinical research. The CATALIS Network brings together more than 250 experts from the public and private sectors, including patient representatives, who are all working together to drive clinical research in Quebec.
CATALIS gratefully acknowledges the efforts of Montreal InVivo and CQDM for their invaluable contribution in its creation.
